Edwards Lifesciences News

Edwards Lifesciences Corporation -- USA Stock  

USD 121.72  1.23  1.02%

Macroaxis does not monitor all media channels or aggregates social signals for Edwards Lifesciences. But even though we do not provide professional-grade financial sentiment analysis on Edwards Lifesciences, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Edwards Lifesciences. Additionally see Edwards Lifesciences Hype Analysis, Edwards Lifesciences Correlation and Edwards Lifesciences Performance
  
few hours ago at claytonnewsreview.com         
A Look into Edwards Lifesciences Corp as Shares Move 0.02
news
Edwards Lifesciences Corp shares are moving today on volatility 0.02 percent or 0.02 from the open. The NYSE listed company saw a recent bid of 120.51 and 167500 shares have traded hands in the session.
  
  
a day ago at stocksnewstimes.com         
Exercise or conversion by Larry Wood of 6300 shares of Edwards Lifesciences subject to Rule 16b-3
news
Filed transaction by Edwards Lifesciences Corp officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
2 days ago at www.macroaxis.com         
Sale by Patrick Verguet of 2000 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  
  
3 days ago at allstocknews.com         
A Technical Strategy for Xylem Inc. , Edwards Lifesciences Corporation
news
The average volume for Xylem Inc. has been 0.81 million shares per day over the past 30 days. XYL has a 1-week performance of 1.78. Investment Grade Analysis On These Stocks Edwards Lifesciences Corporation ... - Financial Newsweek Keybank National Association Increased Its Edwards Lifesciences Position ... - UtahHerald.com
  
  
few days ago at aikenadvocate.com         
Market Scope Edwards Lifesciences Corp Ratcheting Up Investor Interest
news
The RSI was developed by J. Welles Wilder in the late 197039s. Wilder laid out the foundation for future technical analysts to further investigate the RSI and its relationship to underlying price movements.
  
  
few days ago at www.macroaxis.com         
Exercise or conversion by Redmond Paul C of 17200 shares of Edwards Lifesciences subject to Rule 16b...
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
six days ago at www.macroaxis.com         
Sale by Donald Bobo of 4919 shares of Edwards Lifesciences
Macroaxis News
Filed transaction by Edwards Lifesciences Corp officer. General open market or private sale of non-derivative or derivative security
  
  
over a week ago at financialqz.com         
Basic Stock Data on Edwards Lifesciences Corporation
news
In the past 52-week period, shares of Edwards Lifesciences Corporation have moved within the range of 86.55 to 121.45. 32800 Shares Of Edwards Lifesciences Corporation sold By MUSSALLEM MICHAEL A - Economic News How Many Edwards Lifesciences Corporation Analysts Are Bearish - Frisco Fastball
  
  
over a week ago at economicsandmoney.com         
32800 Shares Of Edwards Lifesciences Corporation sold By MUSSALLEM MICHAEL A
news
Edwards Lifesciences Corporation has seen its stock price gain 5.43, or 4.82, so far in 2017. In the past 3-month period alone, shares of EW have appreciated 6.68 - or 5.99. How Many Edwards Lifesciences Corporation Analysts Are Bearish - Frisco Fastball Edwards Lifesciences Corp CEO Michael A. Mussallem Sells 32800 Shares of ... - StockNewsTimes
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Michael Mussallem of 32800 shares of Edwards Lifesciences subject to Rule ...
Macroaxis News
Filed transaction by Edwards Lifesciences Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at friscofastball.com         
Analysts See 0.90 EPS for Edwards Lifesciences Corporation
news
Analysts expect Edwards Lifesciences Corporation to report 0.90 EPS on February, 7.They anticipate 0.15 EPS change or 20.00 percent from last quarter 0.75 EPS. Equities Analysts Set Expectations for Edwards Lifesciences Corp Q2 2018 ... - The Ledger Gazette Riverpark Advisors LLC Has Raised Edwards Lifesciences Corp Position by ... - MoneyMakingArticles
  
  
over a week ago at www.hillcountrytimes.com         
South Texas Money Management LTD Stake in Edwards Lifesciences Has ...
news
South Texas Money Management Ltd increased its stake in Edwards Lifesciences Corp by 0.82 percent based on its latest 2017Q3 regulatory filing with the SEC.
  
  
over a week ago at normanweekly.com         
Icon Advisers Lowered Edwards Lifesciences Corp. Stake By 2.93 Million ...
news
Icon Advisers Inc decreased Edwards Lifesciences Corp. stake by 48.47 percent reported in 2017Q3 SEC filing. Icon Advisers Inc sold 26,900 shares as Edwards Lifesciences Corp. stock rose 25.80. The Icon Advisers Inc holds 28,600 shares with 3 ...
  
  
over a week ago at stocknewsgazette.com         
Sale by Michael Mussallem of 8903 shares of Edwards Lifesciences
news
Filed transaction by Edwards Lifesciences Corp director. General open market or private sale of non-derivative or derivative security
  
  
over two weeks ago at aikenadvocate.com         
Trading Watch Checking the Numbers on Shares of Edwards Lifesciences Corp
news
Let check in on some recent stock price information on shares of Edwards Lifesciences Corp . At the time of writing, shares had most recently hit 112.72.
  

Contributor Headline

Latest Prospective on Edwards Lifesciences
Edwards Lifesciences
  2 days ago at Macroaxis
Filed for Patrick Verguet
Sale by Spencer Rascoff of 56850 shares of Zillow
January 19, 2018 for Spencer Rascoff
Mid Penn exotic insider transaction detected
January 18, 2018 for Lawrence Keister Co
View All Premium Stories  
Price Growth (%)  
      Timeline 
1
The Markets Are Undervaluing these stock Intercontinental Ex...12/27/2017
2
A Look into Edwards Lifesciences Corp as Shares Move 0.0201/18/2018

Earnings

Edwards Lifesciences Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.83April 25, 2017
Edwards Lifesciences Corporation normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Pair Trading

Edwards Lifesciences Pair Trading Analysis
Correlation analysis and pair trading evaluation for Edwards Lifesciences and Express Scripts Holding. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Total Debt

Edwards Lifesciences Total Debt
Based on latest financial disclosure Edwards Lifesciences Corporation has Total Debt of 1.03 B. This is 57.07% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Products industry, The Total Debt for all stocks is 86.01% higher than the company.
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.